Literature DB >> 18036796

Basic fibroblast growth factor regulates expression of heparan sulfate in human periodontal ligament cells.

Yoshio Shimabukuro1, Tomoo Ichikawa, Yoshimitsu Terashima, Tomoaki Iwayama, Hiroyuki Oohara, Tetsuhiro Kajikawa, Ryohei Kobayashi, Hiroaki Terashima, Masahide Takedachi, Mami Terakura, Tomoko Hashikawa, Satoru Yamada, Shinya Murakami.   

Abstract

Heparan sulfate (HS) proteoglycan is a widely distributed biological molecule that mediates a variety of physiological responses in development, cell growth, cell migration, and wound healing. We examined the effects of basic fibroblast growth factor-2 (FGF-2), which is known to modulate extracellular matrix (ECM) production of various cell types, on the production of HS proteoglycan by human periodontal ligament (HPDL) cells. We also examined the effects of FGF-2 on the expression of syndecans, a major family of membrane-bound HS proteoglycans. Treatment of HPDL cells with FGF-2 for 72 h resulted in a pronounced increase in the level of HS in the culture supernatant in a dose-dependent manner. However, reverse transcription-polymerase chain reaction data (RT-PCR) revealed that FGF-2 marginally reduced the gene expression of syndecan-1, -2, and -4, and did not alter the level of syndecan-3 mRNA. Furthermore, FGF-2 did not have an effect on the mRNA expression of enzymes associated with HS biosynthesis. Interestingly, FACS analysis revealed that the syndecan family displayed diverse alterations in response to FGF-2. FGF-2 barely altered the expression of syndecan-1, but decreased the expression of syndecan-2 and -4 on HPDL cells. Moreover, dot blot analysis showed that FGF-2 did not alter the level of syndecan-1 and -2, but enhanced the level of syndecan-4 in culture supernatants of FGF-2-stimulated HPDL cells. These results suggest that the FGF-2-activated increase in the level of HS in conditioned medium may be a result of shedding of syndecan-4 from the HPDL cell surface. Taken together, FGF-2 may differentially regulate the expression of HS proteoglycans in a HS-proteoglycan-subtype-dependent manner. The diversity of the expression patterns of HS proteoglycans may be associated with the FGF-2-induced biological functions of HPDL cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036796     DOI: 10.1016/j.matbio.2007.10.005

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  6 in total

1.  Syndecan-1 and syndecan-2 play key roles in herpes simplex virus type-1 infection.

Authors:  Sarolta Bacsa; Ghadah Karasneh; Sandor Dosa; Jian Liu; Tibor Valyi-Nagy; Deepak Shukla
Journal:  J Gen Virol       Date:  2010-12-09       Impact factor: 3.891

2.  Analysis of a gain-of-function FGFR2 Crouzon mutation provides evidence of loss of function activity in the etiology of cleft palate.

Authors:  Alison K Snyder-Warwick; Chad A Perlyn; Jing Pan; Kai Yu; Lijuan Zhang; David M Ornitz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

3.  Type 1 fibroblast growth factor receptor in cranial neural crest cell-derived mesenchyme is required for palatogenesis.

Authors:  Cong Wang; Julia Yu Fong Chang; Chaofeng Yang; Yanqing Huang; Junchen Liu; Pan You; Wallace L McKeehan; Fen Wang; Xiaokun Li
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

Review 4.  An insight into the possibilities of fibroblast growth factor in periodontal regeneration.

Authors:  Sameera G Nath; Ranjith Raveendran
Journal:  J Indian Soc Periodontol       Date:  2014-05

5.  Syndecan-2 is upregulated in colorectal cancer cells through interactions with extracellular matrix produced by stromal fibroblasts.

Authors:  Carolina Meloni Vicente; Ritchelli Ricci; Helena Bonciani Nader; Leny Toma
Journal:  BMC Cell Biol       Date:  2013-05-25       Impact factor: 4.241

6.  Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial.

Authors:  Masahiro Kitamura; Keisuke Nakashima; Yusuke Kowashi; Takeo Fujii; Hidetoshi Shimauchi; Takashi Sasano; Toshi Furuuchi; Mitsuo Fukuda; Toshihide Noguchi; Toshiaki Shibutani; Yukio Iwayama; Shogo Takashiba; Hidemi Kurihara; Masami Ninomiya; Jun-ichi Kido; Toshihiko Nagata; Takafumi Hamachi; Katsumasa Maeda; Yoshitaka Hara; Yuichi Izumi; Takao Hirofuji; Enyu Imai; Masatoshi Omae; Mitsuru Watanuki; Shinya Murakami
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.